EcoDrugPlus

Integrin Subunit Beta 7

Ensembl ID : ENSDCDG00000023597
Gene Symbol: ITGB7
2 Cross references
149 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSDCDG00000027510
Gene Symbol: ITGB8
3 Cross references
206 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSDCDG00000030804
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Inward Rectifier Potassium Channel 2-Like

Ensembl ID : ENSDCDG00000003911
Gene Symbol: LOC114784362
3 Cross references
202 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSDCDG00000035020
Gene Symbol: IDH1
3 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSDCDG00000009186
Gene Symbol: IDH2
3 Cross references
250 Possible Orthologues:

Isotocin Receptor-Like

Ensembl ID : ENSDCDG00000034513
Gene Symbol: LOC114800439
3 Cross references
193 Possible Orthologues:

Isotocin Receptor-Like

Ensembl ID : ENSDCDG00000029854
Gene Symbol: LOC114801060
3 Cross references
136 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSDCDG00000031248
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSDCDG00000025607
Gene Symbol: KDR
3 Cross references
198 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSDCDG00000004413
Gene Symbol: KIF11
3 Cross references
200 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSDCDG00000030549
Gene Symbol: KIF5B
3 Cross references
274 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).